These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37008178)

  • 1. Control of diabetes, hypertension, and dyslipidemia in Jordan: a cross-sectional study.
    Hyassat D; Abu Noor N; AlAjlouni Q; Jarrar Y; Qarajeh R; Mahasneh A; Elzoubi Z; Khader Y; Farahid O; El-Khateeb M; Ajlouni K
    Ann Med Surg (Lond); 2023 Mar; 85(3):439-445. PubMed ID: 37008178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study.
    Hu H; Hori A; Nishiura C; Sasaki N; Okazaki H; Nakagawa T; Honda T; Yamamoto S; Tomita K; Miyamoto T; Nagahama S; Uehara A; Yamamoto M; Murakami T; Shimizu C; Shimizu M; Eguchi M; Kochi T; Imai T; Okino A; Kuwahara K; Kashino I; Akter S; Kurotani K; Nanri A; Kabe I; Mizoue T; Kunugita N; Dohi S;
    PLoS One; 2016; 11(7):e0159071. PubMed ID: 27437997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidemia among patients with type 2 diabetes in Jordan: Prevalence, pattern, and associated factors.
    Hyassat D; Al-Saeksaek S; Naji D; Mahasneh A; Khader Y; Abujbara M; El-Khateeb M; Ajlouni K
    Front Public Health; 2022; 10():1002466. PubMed ID: 36424970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan.
    Al-Eitan LN; Nassar AM; Saadeh NA; Almomani BA
    Can J Diabetes; 2016 Dec; 40(6):496-502. PubMed ID: 27212046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
    Raman R; Gupta A; Kulothungan V; Sharma T
    Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study.
    Achila OO; Ghebretinsae M; Kidane A; Simon M; Makonen S; Rezene Y
    J Diabetes Res; 2020; 2020():5901569. PubMed ID: 32090121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achievement of national clinical practice recommendations among those in the Puerto Rican population with diabetes mellitus.
    Rodríguez-Vigil E; Rodríguez-Chacón M; Trabanco C; Irizarry-Ramos J
    P R Health Sci J; 2014 Dec; 33(4):157-62. PubMed ID: 25563032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic and non-glycemic targets in younger and older North Indian subjects with type 2 diabetes in a Tertiary care hospital: A 10 year's retrospective data analysis.
    Ahmad J; Zubair M; Malik N; D Z; Raghav A
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S130-4. PubMed ID: 26564028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous control of blood glucose, blood pressure, and lipid among drug-treated Type 2 diabetes patients from Shaanxi province, North-Western China: A multicenter study.
    Xu S; Sun F; Xu W; Jiao K; Shi B; Xie X; Wang Y; Zhu M; Ji Q
    Niger J Clin Pract; 2016; 19(6):784-792. PubMed ID: 27811452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and correlation of glycemic control achievement in patients with type 2 diabetes in Iraq: A retrospective analysis of a tertiary care database over a 9-year period.
    Mansour AA; Alibrahim NTY; Alidrisi HA; Alhamza AH; Almomin AM; Zaboon IA; Kadhim MB; Hussein RN; Nwayyir HA; Mohammed AG; Al-Waeli DKJ; Hussein IH;
    Diabetes Metab Syndr; 2020; 14(3):265-272. PubMed ID: 32272433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China.
    Bi Y; Zhu D; Cheng J; Zhu Y; Xu N; Cui S; Li W; Cheng X; Wang F; Hu Y; Shen S; Weng J
    Clin Ther; 2010 May; 32(5):973-83. PubMed ID: 20685506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dyslipidemia in patients with type 2 diabetes in Jordan.
    Abdel-Aal NM; Ahmad AT; Froelicher ES; Batieha AM; Hamza MM; Ajlouni KM
    Saudi Med J; 2008 Oct; 29(10):1423-8. PubMed ID: 18946566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors associated with the optimum simultaneous control of diabetes, arterial hypertension and hypercholesterolemia in the diabetic population. BPC Diabetes study].
    Llisterri-Caro JL; Turégano-Yedro M; Cinza-Sanjurjo S; Segura-Fragoso A; Sánchez-Sánchez B; Cubelos-Fernández N; Velilla-Zancada S; Micó-Pérez RM; Martín-Sánchez V;
    Semergen; 2022; 48(4):225-234. PubMed ID: 34479796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management status and its predictive factors in patients with type 2 diabetes in China: A Nationwide Multicenter Study: A Nationwide Multicenter Study.
    Liu L; Lou Q; Guo X; Yuan L; Shen L; Sun Z; Zhao F; Dai X; Huang J; Yang H; Mordes JP;
    Diabetes Metab Res Rev; 2015 Nov; 31(8):811-6. PubMed ID: 26455830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cross-sectional epidemiological study of clinical profiles and glycemic control in diabetic patients in primary care in Spain (the EPIDIAP study)].
    de Pablos Velasco P; Franch J; Banegas Banegas JR; Fernández Anaya S; Sicras Mainar A; Díaz Cerezo S
    Endocrinol Nutr; 2009 May; 56(5):233-40. PubMed ID: 19627744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Determinants of Occurrence of Dyslipidemia in Subjects with Type 1 Diabetes Mellitus.
    Selvaraj M; Prasad HK; White S; Prasanna B; Sangaralingam T
    Indian J Pediatr; 2023 Feb; 90(2):118-123. PubMed ID: 35366198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycemic control and diabetic dyslipidemia in adolescents with type 2 diabetes.
    Le PT; Huisingh CE; Ashraf AP
    Endocr Pract; 2013; 19(6):972-9. PubMed ID: 23807519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic control and treatment patterns in patients with type 1 diabetes in Castilla-La Mancha: the DIAbetes tipo 1 in Castilla La Mancha study.
    Sastre J; Pinés PJ; Moreno J; Aguirre M; Blanco B; Calderón D; Herranz S; Roa C; Lopez J;
    Endocrinol Nutr; 2012 Nov; 59(9):539-46. PubMed ID: 23039989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.